Sevirumab

Tax included
Sevirumab (MSL-109) is a human IgG1 neutralizing monoclonal antibody against cytomegalovirus (CMV). Sevirumab recognizes CMV gH complexes and inhibits CMV replication with an EC50 of 0.3 μg/mL.
MedChemExpress 
HY-P99900

Data sheet

Size
Multiple sizes
Reactivity
CMV
CAS
138660-96-5